PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells
Qi Sun(Shanxi University), Jian Yu(University of Southern California), Sufi M. Thomas(University of New Mexico), Yi-Jun Wang(University of Pittsburgh), Z G Chen(Emory University), Robert L. Ferris(University of Pittsburgh), Jennifer R. Grandis(University of California, San Francisco), Lin Zhang(Mudanjiang Medical University), Lihua Ming(University of Pittsburgh)
Cited by 69
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
Is a p53-Regulated Inhibitor of G2/M Progression
|Molecular Cell|1997|1.2k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Analysis of human transcriptomes
|Nature Genetics|1999|789